Jim Kelly
Executive Vice President and Chief Financial Officer
Replay available
Novavax, Inc. (NVAX) Q1 2026 Earnings Call
Novavax, Inc. (NASDAQ: NVAX) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Sean Jacobs
President and Chief Executive Officer
Elaine O'Hara
Chief Strategy Officer
Bob Walker
Head of Research and Development
Pete Stavropoulos
Analyst at Cantor Fitzgerald
Roger Song
Analyst at Jefferies
Mayank Mamtani
Analyst at B. Riley Securities
Tom Schroeder
Analyst at VTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Novavax, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.076 Good morning and welcome to the NOVAVAC's first quarter 2026 financial results 00:00:05.076 -- 00:00:07.838 and operational highlights conference call. 00:00:07.838 -- 00:00:10.081 All participants will be in a listen-only mode. 00:00:10.081 -- 00:00:14.224 Should you need assistance, please signal the conference specialist by pressing the star 00:00:14.224 -- 00:00:19.349 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:19.349 -- 00:00:25.335 questions. To ask a question, you may press star followed by the digit one on your touchtone. 00:00:25.335 -- 00:00:30.203 To withdraw your question, please press star and then digit one once again. 00:00:30.203 -- 00:00:32.305 Please note, this event is being recorded. 00:00:32.305 -- 00:00:37.630 It is now my pleasure to turn the conference over to Jim Kelly, Executive Vice President 00:00:37.630 -- 00:00:40.392 and Chief Financial Officer. Please go ahead. 00:00:40.392 -- 00:00:43.133 The floor is yours, sir. 00:00:44.275 -- 00:00:49.420 Good morning, and thank you for joining us today to discuss our first quarter, 2026, 00:00:49.420 -- 00:00:53.083 financial results and operational highlights. 00:00:53.083 -- 00:00:58.857 A press release announcing our results is available on our website at Novavax.com. 00:00:58.857 -- 00:01:05.045 and an audio archive of this conference call will be available on our website later today. 00:01:05.045 -- 00:01:07.689 Please turn to slide two. 00:01:07.689 -- 00:01:12.716 Before we begin with prepared remarks, I need to remind you that this presentation 00:01:12.716 -- 00:01:17.882 includes forward-looking statements including, but not limited to, statements 00:01:17.882 -- 00:01:23.009 related to Novavax's corpora...